• OPEN AN ACCOUNT
Indian Indices
Sensex
83,160.13 -153.80
( -0.18%)
Global Indices
Nasdaq
48,934.28 -588.03
(-1.19%)
Dow Jones
6,820.12 -83.60
(-1.21%)
Hang Seng
53,872.74 -420.62
(-0.77%)
Nikkei 225
10,300.09 -102.25
(-0.98%)
Forex
USD-INR
90.39 0.07
(0.07%)
EUR-INR
106.79 0.14
(0.13%)
GBP-INR
123.73 0.13
(0.10%)
JPY-INR
0.58 0.00
(-0.49%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
32.9918134
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
33.75
8136.56
EPS(TTM)
Face Value()
Div & Yield %
5.32
1
0.45
 

piramal enterprises ltd
Global Vectra Helicorp reports standalone net loss of Rs 6.16 crore in the September 2025 quarter
Nov 11,2025
Net Loss of Global Vectra Helicorp reported to Rs 6.16 crore in the quarter ended September 2025 as against net loss of Rs 4.15 crore during the previous quarter ended September 2024. Sales declined 5.37% to Rs 117.62 crore in the quarter ended September 2025 as against Rs 124.30 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales117.62124.30 -5
OPM %5.0710.10 -
PBDT11.3613.06 -13
PBT-8.04-4.86 -65
NP-6.16-4.15 -48